ORAI1 and Familial prostate cancer: Among them, TRPV6 is overexpressed in a number of cancer cell types and participates in the progression of prostate cancer [19], acquiring its oncogenic potential via Orai1/TRPC1-dependent translocation to the plasma membrane [20].